Skip to content
Menu

aTyr Pharma Q3 EPS $(7.43) Misses $(4.00) Estimate

Benzinga Newsdesk 2 weeks ago

NewsEarningsEarnings Misses

This page contains a summary, not the full article. Continue to benzinga.com to read the original report.

aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(4.00) by 85.75 percent. This is a 2757.69 percent decrease over losses of $(0.26) per share from

aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(7.43) per share which missed the analyst consensus estimate of $(4.00) by 85.75 percent. This is a 2757.69 percent decrease over losses of $(0.26) per share from the same period last year.

Read at benzinga.com